1. Home
  2. PRLB vs RAPP Comparison

PRLB vs RAPP Comparison

Compare PRLB & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$52.20

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.28

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLB
RAPP
Founded
1999
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
PRLB
RAPP
Price
$52.20
$30.28
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$53.00
$47.80
AVG Volume (30 Days)
147.4K
417.7K
Earning Date
02-06-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$518,384,000.00
N/A
Revenue This Year
$7.07
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$86.10
N/A
Revenue Growth
2.82
N/A
52 Week Low
$29.59
$6.43
52 Week High
$55.90
$42.27

Technical Indicators

Market Signals
Indicator
PRLB
RAPP
Relative Strength Index (RSI) 53.48 55.51
Support Level $51.81 $28.99
Resistance Level $53.53 $31.52
Average True Range (ATR) 1.09 1.88
MACD -0.01 -0.04
Stochastic Oscillator 54.49 54.51

Price Performance

Historical Comparison
PRLB
RAPP

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: